New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Immuneering Corporation
IMRX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

60M

Biotechnology

Next Earning date - 06 May 2025

60M

Biotechnology

Next Earning date - 06 May 2025

1.77USD

Shape-0.07 ( -3.80%)
Market Open
favorite-chart

Relative Strenght

20
favorite-chart

Volume Buzz

-87%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

54%

Quote Panel

Shape
Updated March 27, 2025
1W -6.94 % 1M 1.52 % 3M -25.56 % 1Y -42.04 %

Key Metrics

Shape
  • Market Cap

    60.11M


  • Shares Outstanding

    35.89M


  • Share in Float

    25.89M


  • Dividende

    0


  • Earning Date

    06 May 2025


  • Price Target

    1.675


  • Average Volume

    1.81M


  • Beta

    -0.327


  • Range

    1-3.83


  • Industry

    Biotechnology


  • Website

    https://immuneering.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

IMRX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1M

ShapeNaN%

2025-Revenue

$1.88

Shape-213%

2025-EPS

$218K

Shape99%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Morgan Stanley

downgrade

Previous: Not converted

2024-12-13

Now: Underweight

Mizuho Securities

upgrade

Previous: Not converted

2023-04-19

Now: Buy

Chardan Capital

initialise

Previous: Not converted

2022-07-09

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.51
vs -0.49

Q2.23

arrow
arrow

N/A

-0.43
vs -0.44

Q3.23

arrow
arrow

N/A

-0.43
vs -0.49

Q4.23

arrow
arrow

N/A

-0.52
vs -0.50

Q1.24

arrow
arrow

N/A

-0.49
vs -0.51

Q2.24

arrow
arrow

N/A

-0.47
vs -0.43

Q3.24

arrow
arrow

N/A

-0.49
vs -0.43

Q4.24

arrow
arrow

N/A

-0.58
vs -0.52

Q1.25

arrow
arrow

N/A

-0.53
vs -0.49

Q2.25

arrow
arrow

N/A

-0.44
vs -0.47

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-92%

38.4K  vs 482.1K

Q4.22

arrow
arrow

-100%

456  vs 189.6K

Q1.23

arrow
arrow

-100%

NA  vs 183.7K

Q2.23

arrow
arrow

+99900%

94.4M  vs 94.4K

Q3.23

arrow
arrow

-100%

NA  vs 38.4K

Q4.23

arrow
arrow

-20706021%

-94419000.00  vs 456

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

-100%

NA  vs 94.4M

Q3.24

arrow
arrow

NA

NA  vs NA

Q4.24

arrow
arrow

+100%

NA  vs -94419000

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

+1086%

10.86
vs -0.11

Q2.23

arrow
arrow

-11%

-0.11
vs 10.86

Q3.23

arrow
arrow

-12%

-0.12
vs -0.11

Q4.23

arrow
arrow

-17%

-0.17
vs -0.12

Q1.24

arrow
arrow

-18%

-0.18
vs -0.17

Q2.24

arrow
arrow

-21%

-0.21
vs -0.18

Q3.24

arrow
arrow

-25%

-0.25
vs -0.21

Q4.24

arrow
arrow

-44%

-0.44
vs -0.25

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

34

34
vs 32

6%

Q2.23

arrow
arrow

49

49
vs 34

44%

Q3.23

arrow
arrow

53

53
vs 49

8%

Q4.23

arrow
arrow

52

52
vs 53

-2%

Q1.24

arrow
arrow

50

50
vs 52

-4%

Q2.24

arrow
arrow

56

56
vs 50

12%

Q3.24

arrow
arrow

38

38
vs 56

-32%

Q4.24

arrow
arrow

42

42
vs 38

11%

Earnings Growth

Latest News